Citigroup’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.7M | Buy |
28,400
+4,000
| +16% | +$1.87M | 0.01% | 1326 |
|
|
2025
Q4 | $11.1M | Sell |
24,400
-3,900
| -14% | -$1.68M | ﹤0.01% | 1459 |
|
|
2025
Q3 | $11.1M | Hold |
28,300
| – | – | ﹤0.01% | 1407 |
|
|
2025
Q2 | $12.6M | Buy |
28,300
+19,900
| +237% | +$9.17M | 0.01% | 1235 |
|
|
2025
Q1 | $4.07M | Sell |
8,400
-55,100
| -87% | -$25.7M | ﹤0.01% | 2091 |
|
|
2024
Q4 | $25.6M | Buy |
63,500
+16,300
| +35% | +$7.56M | 0.02% | 823 |
|
|
2024
Q3 | $22M | Buy |
47,200
+17,100
| +57% | +$8.21M | 0.01% | 892 |
|
|
2024
Q2 | $14.1M | Sell |
30,100
-32,600
| -52% | -$14.1M | 0.01% | 1070 |
|
|
2024
Q1 | $26.2M | Sell |
62,700
-27,800
| -31% | -$11.8M | 0.02% | 766 |
|
|
2023
Q4 | $36.8M | Buy |
90,500
+35,300
| +64% | +$13M | 0.03% | 577 |
|
|
2023
Q3 | $19.2M | Buy |
55,200
+34,700
| +169% | +$12.1M | 0.01% | 791 |
|
|
2023
Q2 | $7.21M | Buy |
+20,500
| New | +$6.91M | ﹤0.01% | 1290 |
|
|
2023
Q1 | – | Sell |
-12,000
| Closed | -$3.47M | – | 5895 |
|
|
2022
Q4 | $3.47M | Sell |
12,000
-15,000
| -56% | -$4.57M | ﹤0.01% | 1684 |
|
|
2022
Q3 | $7.82M | Buy |
27,000
+10,200
| +61% | +$2.93M | 0.01% | 1274 |
|
|
2022
Q2 | $4.73M | Sell |
16,800
-118,400
| -88% | -$31.7M | ﹤0.01% | 1572 |
|
|
2022
Q1 | $35.3M | Buy |
135,200
+128,200
| +1,831% | +$30.4M | 0.02% | 640 |
|
|
2021
Q4 | $1.54M | Hold |
7,000
| – | – | ﹤0.01% | 2841 |
|
|
2021
Q3 | $1.27M | Sell |
7,000
-8,600
| -55% | -$1.68M | ﹤0.01% | 2902 |
|
|
2021
Q2 | $3.15M | Buy |
+15,600
| New | +$3.26M | ﹤0.01% | 2300 |
|
|
2021
Q1 | – | Sell |
-59,100
| Closed | -$14M | – | 7470 |
|
|
2020
Q4 | $14M | Sell |
59,100
-1,300
| -2% | -$298K | 0.01% | 1292 |
|
|
2020
Q3 | $16.4M | Sell |
60,400
-21,100
| -26% | -$5.82M | 0.01% | 1017 |
|
|
2020
Q2 | $23.7M | Sell |
81,500
-4,600
| -5% | -$1.25M | 0.02% | 736 |
|
|
2020
Q1 | $20.5M | Sell |
86,100
-150,600
| -64% | -$34.5M | 0.02% | 721 |
|
|
2019
Q4 | $51.8M | Buy |
236,700
+34,400
| +17% | +$6.96M | 0.04% | 495 |
|
|
2019
Q3 | $34.3M | Buy |
202,300
+26,900
| +15% | +$4.76M | 0.03% | 629 |
|
|
2019
Q2 | $32.2M | Sell |
175,400
-5,700
| -3% | -$996K | 0.03% | 652 |
|
|
2019
Q1 | $33.3M | Buy |
181,100
+95,400
| +111% | +$17.6M | 0.03% | 560 |
|
|
2018
Q4 | $14.2M | Buy |
85,700
+28,600
| +50% | +$4.96M | 0.01% | 1024 |
|
|
2018
Q3 | $11M | Sell |
57,100
-10,600
| -16% | -$1.89M | 0.01% | 1222 |
|
|
2018
Q2 | $11.5M | Buy |
67,700
+31,600
| +88% | +$4.9M | 0.01% | 1189 |
|
|
2018
Q1 | $5.88M | Sell |
36,100
-5,400
| -13% | -$882K | ﹤0.01% | 1632 |
|
|
2017
Q4 | $6.22M | Sell |
41,500
-31,300
| -43% | -$4.63M | 0.01% | 1635 |
|
|
2017
Q3 | $11.1M | Buy |
72,800
+32,000
| +78% | +$4.82M | 0.01% | 1166 |
|
|
2017
Q2 | $5.26M | Sell |
40,800
-46,200
| -53% | -$5.56M | ﹤0.01% | 1655 |
|
|
2017
Q1 | $9.51M | Buy |
87,000
+34,300
| +65% | +$3.02M | 0.01% | 1169 |
|
|
2016
Q4 | $3.88M | Sell |
52,700
-900
| -2% | -$73.2K | ﹤0.01% | 2124 |
|
|
2016
Q3 | $4.67M | Buy |
53,600
+11,800
| +28% | +$1.12M | ﹤0.01% | 1729 |
|
|
2016
Q2 | $3.6M | Buy |
41,800
+3,200
| +8% | +$277K | ﹤0.01% | 1872 |
|
|
2016
Q1 | $3.07M | Buy |
38,600
+4,000
| +12% | +$362K | ﹤0.01% | 2031 |
|
|
2015
Q4 | $4.35M | Sell |
34,600
-9,800
| -22% | -$1.18M | ﹤0.01% | 1816 |
|
|
2015
Q3 | $4.62M | Buy |
44,400
+21,000
| +90% | +$2.7M | ﹤0.01% | 1730 |
|
|
2015
Q2 | $2.89M | Buy |
23,400
+10,200
| +77% | +$1.29M | ﹤0.01% | 2214 |
|
|
2015
Q1 | $1.56M | Sell |
13,200
-119,000
| -90% | -$14.3M | ﹤0.01% | 2692 |
|
|
2014
Q4 | $15.7M | Buy |
132,200
+47,900
| +57% | +$5.39M | 0.01% | 942 |
|
|
2014
Q3 | $9.47M | Sell |
84,300
-179,200
| -68% | -$17.1M | 0.01% | 1327 |
|
|
2014
Q2 | $24.9M | Buy |
263,500
+120,500
| +84% | +$8.45M | 0.02% | 658 |
|
|
2014
Q1 | $10.1M | Sell |
143,000
-24,700
| -15% | -$1.96M | 0.01% | 1154 |
|
|
2013
Q4 | $12.5M | Buy |
167,700
+92,000
| +122% | +$6.41M | 0.01% | 1082 |
|
|
2013
Q3 | $5.74M | Sell |
75,700
-113,500
| -60% | -$9.03M | 0.01% | 1641 |
|
|
2013
Q2 | $15.1M | Buy |
+189,200
| New | +$13.9M | 0.01% | 815 |
|
Other funds holding VRTX
VCM
VPM
Citigroup's VRTX Position: Q1 2026 in Review
Citigroup increased its Vertex Pharmaceuticals (VRTX) stake by 26% in Q1 2026, buying an estimated $66.6M and bringing the position to 682,807 shares worth $305M. The position accounts for 0.13% of the portfolio, ranked #153.
Citigroup first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Citigroup held 682,807 shares of Vertex Pharmaceuticals worth $305M as of Q1 2026.
- Citigroup bought 142,877 Vertex Pharmaceuticals shares in Q1 2026, an estimated $66.6M.
- Vertex Pharmaceuticals made up 0.13% of Citigroup's portfolio in Q1 2026, its #153 holding.
- Citigroup first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.